Ontario

Ontario is a global powerhouse for life sciences innovation, ranking among the largest clusters in North America.

The province is best known for its world-class academic research and a highly collaborative biotechnology sector, centered in the Toronto-Waterloo corridor.

Ontario is a leader in regenerative medicine and cell and gene therapy, fueled by the legacy of discovering stem cells and the presence of world-leading institutions like the University of Toronto.

In the pharmaceutical industry, Ontario serves as a critical hub for global giants and contract manufacturing organizations (CMOs) that drive significant R&D investment and drug discovery.

The province’s medical device sector is equally robust, specializing in advanced imaging, digital health and AI-powered diagnostics.

Ontario is also pioneering healthcare innovation through its "Health Innovation Pathway," which streamlines the adoption of cutting-edge technologies into its publicly funded healthcare system.

The ecosystem benefits from a massive talent pipeline, producing thousands of specialized graduates annually across clinical trials, genomics and bioinformatics.

Moreover, the integration of artificial intelligence (AI) in life sciences has made Ontario a premier destination for precision medicine and biomanufacturing.

With generous R&D tax credits and strategic government support, Ontario offers an unparalleled environment for life sciences commercialization and global partnerships.